How the fanconi anemia pathway guards the genome

Annual Review of Genetics

Volumn 43, Issue , 2009, Pages 223-249

  Moldovan, George Lucian ^a   D'Andrea, Alan D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; DNA repair; Homologous recombination; Interstrand crosslink; Protein ubiquitination; Translesion synthesis

Indexed keywords

BRCA2 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; NUCLEAR PROTEIN; PROTEIN FANCI; PROTEIN FANCJ; PROTEIN FANCM; PROTEIN FANCN; UNCLASSIFIED DRUG; FANCONI ANEMIA PROTEIN;

DNA REPAIR; EPISTASIS; EXCISION REPAIR; FANCONI ANEMIA; GENOME; HOMOLOGOUS RECOMBINATION; HUMAN; MUTAGENIC TRANSLESION SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; UBIQUITINATION; ANIMAL; METABOLISM;

ANIMALS; DNA REPAIR; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENOME; HUMANS; METABOLIC NETWORKS AND PATHWAYS;

EID: 72149119542     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-genet-102108-134222     Document Type: Review

References (171)

1. Agoulnik AI, Lu B, Zhu Q, Truong C, Ty MT, et al. 2002. A novel gene, Pog, is necessary for primordial germ cell proliferation in the mouse and underlies the germ cell deficient mutation, gcd. Hum. Mol. Genet. 11:3047-3053
2. Akkari YM, Bateman RL, Reifsteck CA, Olson SB, Grompe M. 2000. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol. Cell Biol. 20:8283-8289
3. Alpi A, Langevin F, Mosedale G, Machida YJ, Dutta A, Patel KJ. 2007. UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol. Cell Biol. 27:8421-8430
4. Alpi AF, Pace PE, Babu MM, Patel KJ. 2008. Mechanistic insight into site-restricted monoubiq-uitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol. Cell 32:767-777
5. Alter BP. 1996. Fanconi's anemia and malignancies. Am. J. Hematol. 53:99-110
6. Alter BP, Greene MH, Velazquez I, Rosenberg PS. 2003. Cancer in Fanconi anemia. Blood 101:2072
7. Alter BP, Rosenberg PS, Brody LC. 2007. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J. Med. Genet. 44:1-9
8. Andreassen PR, D'Andrea AD, Taniguchi T. 2004. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18:1958-1963
9. Auerbach AD. 1988. A test for Fanconi's anemia. Blood 72:366-367
10. Auerbach AD, Wolman SR. 1976. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 261:494-496
11. Baba D, Maita N, Jee JG, Uchimura Y, Saitoh H, et al. 2005. Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature 435:979-982
12. Barber LJ, Ward TA, Hartley JA, McHugh PJ. 2005. DNA interstrand cross-link repair in the Saccha-romyces cerevisiae cell cycle: overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phase. Mol. Cell Biol. 25:2297-2309
13. Bhagwat N, Olsen AL, Wang A, Hanada K, Stuckert P, et al. 2009. XPF-ERCC1 participates in the Fanconi Anemia pathway of crosslink repair. Submitted
14. Bogliolo M, Lyakhovich A, Callen E, Castella M, Cappelli E, et al. 2007. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J. 26:1340-1351
15. Bridge WL, Vandenberg CJ, Franklin RJ, Hiom K. 2005. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat. Genet. 37:953-957
16. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, et al. 2005. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913-917
17. Cantor S, Drapkin R, Zhang F, Lin Y, Han J, et al. 2004. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proc. Natl. Acad. Sci. USA 101:2357-2362
18. Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, et al. 2001. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105:149-160
19. Chan KL, North PS, Hickson ID. 2007. BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges. EMBO J. 26:3397-3409
20. Chan KL, Palmai-Pallag T, Ying S, Hickson ID. 2009. Replication stress induces sister-chromatid bridges at fragile site loci in mitosis. Nat. Cell Biol. 11:753-760
21. Chen M, Tomkins DJ, Auerbach W, McKerlie C, Youssoufian H, et al. 1996. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12:448-451
22. ChenP, Liang J, Wang Z, ZhouX, Chen L, et al. 2008. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study. Clin. Cancer Res. 14:5931-5937
23. Cheung AM, Elia A, Tsao MS, Done S, Wagner KU, et al. 2004. Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice. Cancer Res. 64:1959-1965
24. Ciccia A, Ling C, Coulthard R, Yan Z, Xue Y, et al. 2007. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 25:331-343
25. Ciccia A, McDonald N, West SC. 2008. Structural and functional relationships of the XPF/MUS81 family of proteins. Annu. Rev. Biochem. 77:259-287
26. Cohn MA, Kee Y, Haas W, Gygi SP, D'Andrea AD. 2009. UAF 1isasubunitof multiple deubiquitinating enzyme complexes. J. Biol. Chem. 284:5343-5351
27. Cohn MA, KowalP, YangK, HaasW, Huang TT,et al. 2007.A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol. Cell 28:786-797
28. Collins NB, Wilson JB, Bush T, Tomashevski A, Roberts KJ, et al. 2009. ATR-dependent phospho-rylation of FANCA on serine 1449 after DNA damage is important for FA pathway function. Blood 113:2181-2190
29. Collis SJ, Barber LJ, Ward JD, Martin JS, Boulton SJ. 2006. C. elegans FANCD2 responds to replication stress and functions in interstrand cross-link repair. DNA Repair. (Amst.) 5:1398-1406
30. Collis SJ, Ciccia A, Deans AJ, Horejsi Z, Martin JS, et al. 2008. FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol. Cell 32:313-324
31. Cumming RC, Lightfoot J, Beard K, Youssoufian H, O'Brien PJ, Buchwald M. 2001. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat. Med. 7:814-820
32. D'Andrea AD, Grompe M. 2003. The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 3:23-34
33. Dalle JH. 2008. HSCT for Fanconi anemia in children: factors that influence early and late results. Bone Marrow Transplant. 42(Suppl 2):S51-53
34. Daniels MJ, Wang Y, Lee M, Venkitaraman AR. 2004. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306:876-879
35. De Silva IU, McHugh PJ, Clingen PH, Hartley JA. 2000. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol. Cell Biol. 20:7980-7990
36. de Winter JP, Joenje H. 2008. The genetic and molecular basis of Fanconi anemia. Mutat. Res.:Fundam. Mol. Mech. Mutagen. doi:10.1016/j.mrfmmm.2008.11.004
37. de Winter JP, Leveille F, van Berkel CG, Rooimans MA, Van Der Weel L, et al. 2000. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67:1306-1308
38. de Winter JP, Rooimans MA, Van Der Weel L, van Berkel CG, Alon N, et al. 2000. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat. Genet. 24:15-16
39. de Winter JP, Waisfisz Q, Rooimans MA, van Berkel CG, Bosnoyan-Collins L, et al. 1998. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat. Genet. 20:281-283
40. Dominski Z. 2007. Nucleases of the metallo-beta-lactamase family and their role in DNA and RNA metabolism. Crit. Rev. Biochem. Mol. Biol. 42:67-93
41. Dorsman JC, Levitus M, Rockx D, Rooimans MA, Oostra AB, et al. 2007. Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol. 29:211-218
42. Dronkert ML, Kanaar R. 2001. Repair of DNA interstrand cross-links. Mutat. Res. 486:217-247
43. Dunn J, Potter M, Rees A, Runger TM. 2006. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar UV light. Cancer Res. 66:11140-11147
44. Edwards SL, Brough R, Lord CJ, Natrajan R, Vatcheva R, et al. 2008. Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451:1111-1115
45. -/- mice. J. Immunol. 173:3863-3870
46. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, et al. 2005. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917-921
47. Friedel AM, Pike BL, Gasser SM. 2009. ATR/Mec1: coordinating fork stability and repair. Curr. Opin. Cell Biol. 21:237-244
48. Garcia-HigueraI, KuangY, Denham J, D'Andrea AD. 2000. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 96:3224-3230
49. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, et al. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7:249-262
50. Gari K, Decaillet C, Delannoy M, Wu L, Constantinou A. 2008. Remodeling of DNA replication structures by the branch point translocase FANCM. Proc. Natl. Acad. Sci. USA 105:16107-16112
51. Gari K, Decaillet C, Stasiak AZ, StasiakA, Constantinou A. 2008. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol. Cell 29:141-148
52. German J, Schonberg S, Caskie S, Warburton D, Falk C, Ray JH. 1987. A test for Fanconi's anemia. Blood 69:1637-1641
53. Godthelp BC, Wiegant WW, Waisfisz Q, Medhurst AL, Arwert F, et al. 2006. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat. Res. 594:39-48
54. Gordon SM, Buchwald M. 2003. Fanconi anemia protein complex: mapping protein interactions in the yeast 2-and 3-hybrid systems. Blood 102:136-141
55. Guo C, Sonoda E, Tang TS, Parker JL, Bielen AB, et al. 2006. REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro and in vivo. Mol. Cell 23:265-271
56. Gupta R, Sharma S, Sommers JA, Jin Z, Cantor SB, Brosh RM, Jr. 2005. Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer. J. Biol. Chem. 280:25450-25460
57. Gupta R, Sharma S, Sommers JA, Kenny MK, Cantor SB, Brosh RM, Jr. 2007. FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein. Blood 110:2390-2398
58. Gurtan AM, Stuckert P, D'Andrea AD. 2006. The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly. J. Biol. Chem. 281:10896-10905
59. Hanada K, Budzowska M, Modesti M, Maas A, Wyman C, et al. 2006. The structure-specific endonu-clease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 25:4921-4932
60. Hinz JM, Nham PB, Salazar EP, Thompson LH. 2006. The Fanconi anemia pathway limits the severity of mutagenesis. DNA Repair (Amst.) 5:875-884
61. Hinz JM, Nham PB, Urbin SS, Jones IM, Thompson LH. 2007. Disparate contributionsof the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucleic Acids Res. 35:3733-3740
62. Hirano S, Yamamoto K, Ishiai M, Yamazoe M, Seki M, et al. 2005. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J. 24:418-427
63. Ho GP, Margossian S, Taniguchi T, D'Andrea AD. 2006. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell Biol. 26:7005-7015
64. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. 2002. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419:135-141
65. Hofmann K. 2009. Ubiquitin-binding domains and their role in the DNA damage response. DNA Repair (Amst) 14:544-556
66. Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, et al. 2003. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes. Dev. 17:2021-2035
67. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, et al. 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297:606-609
68. Huang TT, Nijman SM, Mirchandani KD, Galardy PJ, Cohn MA, et al. 2006. Regulationofmonoubiq-uitinated PCNA by DUB autocleavage. Nat. Cell Biol. 8:339-347
69. Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, et al. 2004. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13:1241-1248
70. Ishiai M, Kitao H, Smogorzewska A, Tomida J, Kinomura A, et al. 2008. FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 15:1138-1146
71. Jaspers NG, Raams A, Silengo MC, Wijgers N, Niedernhofer LJ, et al. 2007. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio- skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am. J. Hum. Genet. 80:457-466
72. Kee Y, Kim JM, D'Andrea AD. 2009. Regulated degradation of FANCM in the Fanconi Anemia pathway during mitosis. Genes Dev. 23:549-554
73. Kennedy RD, Chen CC, Stuckert P, Archila EM, De la Vega MA,et al. 2007. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J. Clin. Invest. 117:1440-1449
74. Kennedy RD, D'Andrea AD. 2005. The Fanconi Anemia/BRCA pathway: new facesinthe crowd.Genes Dev. 19:2925-2940
75. Kim JM, Kee Y, Gurtan A, D'Andrea AD. 2008. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood 111:5215-5222
76. Kim JM, Parmar K, Huang M, Weinstock DM, Ruit CA, et al. 2009. Inactivation of murine Usp1 results in genomic instability and a fanconi anemia phenotype. Dev. Cell 16:314-320
77. Kitagawa R, Kastan MB. 2005. The ATM-dependent DNA damage signaling pathway. Cold Spring Harb. Symp. Quant. Biol. 70:99-109
78. Kook H. 2005. Fanconi anemia: current management. Hematology 10(Suppl 1):108-110
79. Koomen M, Cheng NC, van de Vrugt HJ, Godthelp BC, Van Der Valk MA, et al. 2002. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. Hum. Mol. Genet. 11:273-281
80. Kowal P, Gurtan AM, Stuckert P, D'Andrea AD, Ellenberger T. 2007. Structural determinants of human FANCF protein that function in the assembly of a DNA damage signaling complex. J. Biol. Chem. 282:2047-2055
81. Kumaraswamy E, Shiekhattar R. 2007. Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase. Mol. Cell Biol. 27:6733-6741
82. Kuraoka I, Kobertz WR, Ariza RR, Biggerstaff M, Essigmann JM, Wood RD. 2000. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J. Biol. Chem. 275:26632-26636
83. Larminat F, Germanier M, Papouli E, Defais M. 2002. Deficiency in BRCA2 leads to increase in nonconservative homologous recombination. Oncogene 21:5188-5192
84. Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, et al. 2005. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet. 37:934-935
85. Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, et al. 2005. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat. Genet. 37:931-933
86. Ling C, Ishiai M, Ali AM, Medhurst AL, Neveling K, et al. 2007. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J. 26:2104-2114
87. Litman R, Peng M, Jin Z, Zhang F, Zhang J, et al. 2005. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8:255-265
88. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, et al. 1996. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat. Genet. 14:320-323
89. Machida YJ, Machida Y, Chen Y, Gurtan AM, Kupfer GM, et al. 2006. UBE2Tisthe E2in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23:589-596
90. Matsushita N, Kitao H, Ishiai M, Nagashima N, Hirano S, et al. 2005. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19:841-847
91. Medhurst AL, Laghmani el H, Steltenpool J, Ferrer M, Fontaine C, et al. 2006. Evidence for subcom-plexes in the Fanconi anemia pathway. Blood 108:2072-2080
92. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, et al. 2003. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35:165-170
93. Meetei AR, Levitus M, Xue Y, Medhurst AL, Zwaan M, et al. 2004. X-linked inheritance of Fanconi anemia complementation group B. Nat. Genet. 36:1219-1224
94. Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, et al. 2005. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37:958-963
95. Meetei AR, Sechi S, Wallisch M, Yang D, Young MK, et al. 2003. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell Biol. 23:3417-3426
96. Mirchandani KD, McCaffrey RM, D'Andrea AD. 2008. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair (Amst) 7:902-911
97. Moldovan GL, Pfander B, Jentsch S. 2007. PCNA, the maestro of the replication fork. Cell 129:665-679
98. Montes de Oca R, Andreassen PR, Margossian SP, Gregory RC, Taniguchi T, et al. 2005. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood 105:1003-1009
99. Mosedale G, Niedzwiedz W, Alpi A, Perrina F, Pereira-Leal JB, et al. 2005. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12:763-771
100. Naim V, Rosselli F. 2009. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat. Cell Biol. 11:761-768
101. Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, et al. 2002. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell Biol. 4:913-920
102. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, et al. 2005. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. USA 102:1110-1115
103. Niedernhofer LJ, Lalai AS, Hoeijmakers JH. 2005. Fanconi anemia (cross)linked to DNA repair. Cell 123:1191-1198
104. Niedernhofer LJ, Odijk H, Budzowska M, van Drunen E, Maas A, et al. 2004. The structure-specific en-donuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol. Cell Biol. 24:5776-5787
105. Niedzwiedz W, Mosedale G, Johnson M, Ong CY, Pace P, Patel KJ. 2004. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15:607-620
106. Nijman SM, Huang TT, Dirac AM, Brummelkamp TR, Kerkhoven RM, et al. 2005. The deu-biquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17:331-339
107. Nojima K, Hochegger H, Saberi A, Fukushima T, Kikuchi K, et al. 2005. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 65:11704-11711
108. Nookala RK, Hussain S, Pellegrini L. 2007. Insights into Fanconi Anaemia from the structure of human FANCE. Nucleic Acids Res. 35:1638-1648
109. Oestergaard VH, Langevin F, Kuiken HJ, Pace P, Niedzwiedz W, et al. 2007. Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol. Cell 28:798-809
110. Pace P, Johnson M, Tan WM, Mosedale G, Sng C, et al. 2002. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21:3414-3423
111. Papadopoulo D, Guillouf C, Mohrenweiser H, Moustacchi E. 1990. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl. Acad. Sci. USA 87:8383-8387
112. Papadopoulo D, Guillouf C, Porfirio B, Moustacchi E. 1990. Decreased mutagenicity in Fanconi's anemia lymphoblasts following treatment with photoactivated psoralens. Prog. Clin. Biol. Res. 340A:241-248
113. Park WH, Margossian S, Horwitz AA, Simons AM, D'Andrea AD, Parvin JD. 2005. Direct DNA binding activity of the Fanconi anemia D2 protein. J. Biol. Chem. 280:23593-23598
114. Patel KJ, Joenje H. 2007. Fanconi anemia and DNA replication repair. DNA Repair (Amst) 6:885-890
115. Perry P, Evans HJ. 1975. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature 258:121-125
116. Pichierri P, Franchitto A, Rosselli F. 2004. BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. EMBO J. 23:3154-3163
117. Pichierri P, Rosselli F. 2004. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 23:1178-1187
118. Prakash R, Satory D, Dray E, Papusha A, Scheller J, et al. 2009. Yeast Mph1 helicase dissociates Rad51-made D-loops: implications for crossover control in mitotic recombination. Genes Dev. 23:67-79
119. Prasher JM, Lalai AS, Heijmans-Antonissen C, Ploemacher RE, Hoeijmakers JH, et al. 2005. Reduced hematopoietic reservesin DNA interstrand crosslink repair-deficient Ercc1-/-mice. EMBO J.24:861-871
120. Qiao F, Mi J, Wilson JB, Zhi G, Bucheimer NR, et al. 2004. Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway. J. Biol. Chem. 279:46035-46045
121. Raschle M, Knipsheer P, Enoiu M, Angelov T, Sun J, et al. 2008. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell 134:969-980
122. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, et al. 2009. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature doi:10.1038/nature08129
123. Rego MA, Kolling FWT, Howlett NG. 2008. The Fanconi anemia protein interaction network: Casting a wide net. Mutat. Res.:Fundam. Mol. Mech. Mutagen. doi:10.1016/j.mrfmmm.2008.11.018
124. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, et al. 2007. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet. 39:162-164
125. Ridpath JR, NakamuraA, Tano K, Luke AM, SonodaE,et al. 2007. Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. Cancer Res. 67:11117-11122
126. Rosado IV, Niedzwiedz W, Alpi AF, Patel KJ. 2009. The Walker B motif in avian FANCM is required to limit sister chromatid exchanges but it is dispensable for DNA crosslink repair. Nucleic Acids Res. doi:10.1093/nar/gkp365
127. Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, et al. 2008. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 451:1116-1120
128. Sarkar S, Davies AA, Ulrich HD, McHugh PJ. 2006. DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase zeta. EMBO J. 25:1285-1294
129. Sasaki MS. 1975. Is Fanconi's anaemia defective in a process essential to the repair of DNA cross links? Nature 257:501-503
130. Scharer OD. 2005. DNA interstrand crosslinks: natural and drug-induced DNA adducts that induce unique cellular responses. Chembiochem 6:27-32
131. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, et al. 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386:804-810
132. Shimamura A, Montes de Oca R, Svenson JL, Haining N, Moreau LA, et al. 2002. A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood 100:4649-4654
133. Sims AE, Spiteri E, Sims RJ 3rd, Arita AG, Lach FP, et al. 2007. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 14:564-567
134. Singh TR, Bakker ST, Agarwal S,Jansen M,Grassman E, et al. 2009. Impaired FANCD2 monoubiqui-tination and hypersensitivity to camptothecin uniquely characterize Fanconi Anemia complementation group M. Blood doi:10.1182/blood- 2009-02-207811
135. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER 3rd, Hurov KE, et al. 2007. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129:289-301
136. Sridharan D, Brown M, Lambert WC, McMahon LW, Lambert MW. 2003. Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J. Cell Sci. 116:823-835
137. Strathdee CA, Gavish H, Shannon WR, Buchwald M. 1992. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 358:434
138. Sun W, Nandi S, Osman F, Ahn JS, Jakovleska J, et al. 2008. The FANCM ortholog Fml1 promotes recombination at stalled replication forks and limits crossing over during DNA double-strand break repair. Mol. Cell 32:118-128
139. Sung P, Klein H. 2006. Mechanism of homologous recombination: mediators and helicases take on regulatory functions. Nat. Rev. Mol. Cell Biol. 7:739-750
140. Takata M, Kitao H, Ishiai M. 2007. Fanconi anemia: genetic analysis of a human disease using chicken system. Cytogenet Genome Res. 117:346-351
141. Takata M, Sasaki MS, Tachiiri S, Fukushima T, Sonoda E, et al. 2001. Chromosome instability and defective recombinational repairin knockout mutants of thefive Rad51 paralogs. Mol. Cell Biol.21:2858-2866
142. Taniguchi T, D'Andrea AD. 2002. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 100:2457-2462
143. Taniguchi T, D'Andrea AD. 2006. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107:4223-4233
144. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. 2002. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414-2420
145. Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, et al. 2002. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109:459-472
146. Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, et al. 2003. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat. Med. 9:568-574
147. Thompson LH, Hinz JM. 2009. Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mutat Res in press, doi:10.1016/j.mrfmmm.2009.02.003
148. Thompson LH, Hinz JM, Yamada NA, Jones NJ. 2005. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45:128-142
149. Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, et al. 2001. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell 7:241-248
150. Voloshin ON, Vanevski F, Khil PP, Camerini-Otero RD. 2003. Characterization of the DNA damage-inducible helicase DinG from Escherichia coli. J. Biol. Chem. 278:28284-28293
151. Wang W. 2007. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 8:735-748
152. Wang W. 2008. A major switch for the Fanconi anemia DNA damage-response pathway. Nat. Struct. Mol. Biol. 15:1128-1130
153. Wang X, Andreassen PR, D'Andrea AD. 2004. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell Biol. 24:5850-5862
154. Wang X, Kennedy RD, Ray K, Stuckert P, Ellenberger T, D'Andrea AD. 2007. Chk1-mediated phos-phorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell Biol. 27:3098-3108
155. Whitney MA, Royle G, Low MJ, Kelly MA, Axthelm MK, et al. 1996. Germ cell defects and hematopoi-etic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 88:49-58
156. Williams RS, Williams JS, Tainer JA. 2007. Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. Biochem. Cell Biol. 85:509-520
157. Wilson JB, Yamamoto K, Marriott AS, Hussain S, Sung P, et al. 2008. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3. Oncogene 27:3641-3652
158. Wong JC, Alon N, McKerlie C,Huang JR, Meyn MS, Buchwald M. 2003. Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum. Mol. Genet. 12:2063-2076
159. Wu L. 2007. Role of the BLM helicase in replication fork management. DNA Repair (Amst) 6:936-944
160. Wu Y, Shin-ya K, Brosh RM Jr. 2008. FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol. Cell Biol. 28:4116-4128
161. Wu Y, Suhasini AN, Brosh RM. 2008. Welcome the family of FANCJ-like helicases to the block of genome stability maintenance proteins. Cell Mol. Life Sci. 66:1209-1222
162. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, et al. 2007. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet. 39:159-161
163. Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, et al. 2006. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22:719-729
164. Xue Y, Li Y, Guo R, Ling C, Wang W. 2008. FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum. Mol. Genet. 17:1641-1652
165. Yamamoto K, Hirano S, Ishiai M, Morishima K, Kitao H, et al. 2005. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol. Cell Biol. 25:34-43
166. Yan J, Jetten AM. 2008. RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites. Cancer Lett. 271:179-190
167. Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, et al. 2002. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297:1837-1848
168. Yang Y, Kuang Y, Montes De Oca R, Hays T, Moreau L, et al. 2001. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood 98:3435-3440
169. Youds JL, Barber LJ, Boulton SJ. 2008. C. elegans: a model of Fanconi anemia and ICL repair. Mutat. Res.:Fundam. Mol. Mech. Mutagen. doi:10.1016/j.mrfmmm.2008.11
170. Youds JL, Barber LJ, Ward JD, Collis SJ, O'Neil NJ, et al. 2008. DOG-1 is the Caenorhabditis elegans BRIP1/FANCJ homologue and functions in interstrand cross-link repair. Mol. Cell Biol. 28:1470-1479
171. Zhang QS, Eaton L, Snyder ER, Houghtaling S, Mitchell JB, et al. 2008. Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice. Cancer Res. 68:1601-1608